Manuscripts and Publications

Filters: Keyword is Humans  [Clear All Filters]
2018
Rotheram-Borus MJane, Davis E, Rezai R.  2018.  Stopping the rise of HIV among adolescents globally.. Curr Opin Pediatr. 30(1):131-136.
Miller RLin, Strzyzykowski T, Lee K-S, Chiaramonte D, Acevedo-Polakovich I, Spring H, Santiago-Rivera O, Boyer CB, Ellen JM.  2018.  Structural Effects on HIV Risk Among Youth: A Multi-level Analysis.. AIDS Behav. 22(11):3451-3467.
Havens PL, Long D, Schuster GU, Gordon CM, Price G, Wilson CM, Kapogiannis BG, Mulligan K, Stephensen CB.  2018.  Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone.. Antivir Ther. 23(7):623-628.
Gamarel KE, Westfall AO, Lally MA, Hosek S, Wilson CM.  2018.  Tobacco Use and Sustained Viral Suppression in Youth Living with HIV.. AIDS Behav. 22(6):2018-2025.
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, D Harris R et al..  2018.  Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.. Clin Infect Dis. 66(2):220-228.
2017
Bauermeister JA, Golinkoff JM, Muessig KE, Horvath KJ, Hightow-Weidman LB.  2017.  Addressing engagement in technology-based behavioural HIV interventions through paradata metrics.. Curr Opin HIV AIDS. 12(5):442-446.
Philbin MM, Tanner AE, Ma A, Chambers BD, Ware S, Kinnard EN, Hussen SA, Lee S, J Fortenberry D.  2017.  Adolescent and Adult HIV Providers' Definitions of HIV-Infected Youths' Successful Transition to Adult Care in the United States.. AIDS Patient Care STDS. 31(10):421-427.
Tanner AE, Philbin MM, Ma A, Chambers BD, Nichols S, Lee S, J Fortenberry D.  2017.  Adolescent to Adult HIV Health Care Transition From the Perspective of Adult Providers in the United States.. J Adolesc Health. 61(4):434-439.
Kahn JA, Xu J, Kapogiannis BG, Sleasman JW.  2017.  Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.. J Acquir Immune Defic Syndr. 75(2):241-245.
Reisner SL, Jadwin-Cakmak L, Hughto JMWhite, Martinez M, Salomon L, Harper GW.  2017.  Characterizing the HIV Prevention and Care Continua in a Sample of Transgender Youth in the U.S.. AIDS Behav. 21(12):3312-3327.
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N et al..  2017.  Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.. Clin Infect Dis. 64(3):317-325.
Miller RLin, Boyer CB, Chiaramonte D, Lindeman P, Chutuape K, Cooper-Walker B, Kapogiannis BG, Wilson CM, J Fortenberry D.  2017.  Evaluating Testing Strategies for Identifying Youths With HIV Infection and Linking Youths to Biomedical and Other Prevention Services.. JAMA Pediatr. 171(6):532-537.
Boyer CB, Greenberg L, Chutuape K, Walker B, Monte D, Kirk J, Ellen JM.  2017.  Exchange of Sex for Drugs or Money in Adolescents and Young Adults: An Examination of Sociodemographic Factors, HIV-Related Risk, and Community Context.. J Community Health. 42(1):90-100.
Hightow-Weidman LB, Muessig KE, Bauermeister JA, LeGrand S, Fiellin LE.  2017.  The future of digital games for HIV prevention and care.. Curr Opin HIV AIDS. 12(5):501-507.
Mullins TLKowalczy, Zimet G, Lally M, Xu J, Thornton S, Kahn JA.  2017.  HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.. AIDS Patient Care STDS. 31(12):504-516.
Hosek SG, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, Liu N, Brothers J, Mulligan K, Zimet G et al..  2017.  An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.. J Acquir Immune Defic Syndr. 74(1):21-29.
J Fortenberry D, Koenig LJ, Kapogiannis BG, Jeffries CL, Ellen JM, Wilson CM.  2017.  Implementation of an Integrated Approach to the National HIV/AIDS Strategy for Improving Human Immunodeficiency Virus Care for Youths.. JAMA Pediatr. 171(7):687-693.
Knopf AS, Ott MA, Liu N, Kapogiannis BG, Zimet GD, J Fortenberry D, Hosek SG.  2017.  Minors' and Young Adults' Experiences of the Research Consent Process in a Phase II Safety Study of Pre-exposure Prophylaxis for HIV.. J Adolesc Health. 61(6):747-754.
Knopf AS, Gilbert ALewis, Zimet GD, Kapogiannis BG, Hosek SG, J Fortenberry D, Ott MA.  2017.  Moral conflict and competing duties in the initiation of a biomedical HIV prevention trial with minor adolescents.. AJOB Empir Bioeth. 8(3):145-152.
Muessig KE, LeGrand S, Horvath KJ, Bauermeister JA, Hightow-Weidman LB.  2017.  Recent mobile health interventions to support medication adherence among HIV-positive MSM.. Curr Opin HIV AIDS. 12(5):432-441.
Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, D Harris R, Mulligan K, Zimet G et al..  2017.  Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.. JAMA Pediatr. 171(11):1063-1071.
Miller RLin, Reed SJ, Chiaramonte D, Strzyzykowski T, Spring H, Acevedo-Polakovich ID, Chutuape K, Cooper-Walker B, Boyer CB, Ellen JM.  2017.  Structural and Community Change Outcomes of the Connect-to-Protect Coalitions: Trials and Triumphs Securing Adolescent Access to HIV Prevention, Testing, and Medical Care.. Am J Community Psychol. 60(1-2):199-214.
Philbin MM, Tanner AE, Chambers BD, Ma A, Ware S, Lee S, J Fortenberry D.  2017.  Transitioning HIV-infected adolescents to adult care at 14 clinics across the United States: using adolescent and adult providers' insights to create multi-level solutions to address transition barriers.. AIDS Care. 29(10):1227-1234.
Philbin MM, Tanner AE, Duval A, Ellen JM, Kapogiannis B, J Fortenberry D.  2017.  Understanding Care Linkage and Engagement Across 15 Adolescent Clinics: Provider Perspectives and Implications for Newly HIV-Infected Youth.. AIDS Educ Prev. 29(2):93-104.
Gamarel KE, Nelson KM, Brown L, M Fernández I, Nichols S.  2017.  The Usefulness of the CRAFFT in Screening for Problematic Drug and Alcohol Use Among Youth Living with HIV.. AIDS Behav. 21(7):1868-1877.
van den Berg JJ, M Fernández I, Fava JL, Operario D, Rudy BJ, Wilson PA.  2017.  Using Syndemics Theory to Investigate Risk and Protective Factors Associated with Condomless Sex Among Youth Living with HIV in 17 U.S. Cities.. AIDS Behav. 21(3):833-844.
Horvath KJ, Lammert S, LeGrand S, Muessig KE, Bauermeister JA.  2017.  Using technology to assess and intervene with illicit drug-using persons at risk for HIV.. Curr Opin HIV AIDS. 12(5):458-466.
LeGrand S, Muessig KE, Horvath KJ, Rosengren AL, Hightow-Weidman LB.  2017.  Using technology to support HIV self-testing among MSM.. Curr Opin HIV AIDS. 12(5):425-431.
2016
Mullins TLKowalczy, Zimet G, Lally M, Kahn JA.  2016.  Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.. AIDS Patient Care STDS. 30(7):339-48.
Nichols SL, Bethel J, Kapogiannis BG, Li T, Woods SP, E Patton D, Ren W, Thornton SE, Major-Wilson HO, Puga AM et al..  2016.  Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.. J Neurovirol. 22(2):218-30.
Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MIsabel, Rubin D.  2016.  Behavioral and Health Outcomes for HIV+ Young Transgender Women (YTW) Linked To and Engaged in Medical Care.. LGBT Health. 3(2):162-7.
Ruan A, Tobin NH, Mulligan K, Rollie A, Li F, Sleasman J, Aldrovandi GM.  2016.  Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.. J Acquir Immune Defic Syndr. 72(4):372-5.
Miller RLin, Janulis PF, Reed SJ, Harper GW, Ellen J, Boyer CB.  2016.  Creating Youth-Supportive Communities: Outcomes from the Connect-to-Protect® (C2P) Structural Change Approach to Youth HIV Prevention.. J Youth Adolesc. 45(2):301-15.
Harper GW, Tyler ATimmons, Bruce D, Graham L, Wade RM.  2016.  Drugs, Sex, and Condoms: Identification and Interpretation of Race-Specific Cultural Messages Influencing Black Gay and Bisexual Young Men Living with HIV.. Am J Community Psychol. 58(3-4):463-476.
Brown LK, Kennard BD, Emslie GJ, Mayes TL, Whiteley LB, Bethel J, Xu J, Thornton S, Tanney MR, Hawkins LA et al..  2016.  Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.. J Acquir Immune Defic Syndr. 71(1):38-46.
Castillo-Mancilla J, Seifert S, Campbell K, Coleman S, McAllister K, Zheng J-H, Gardner EM, Liu A, Glidden DV, Grant R et al..  2016.  Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.. Antimicrob Agents Chemother. 60(11):6692-6697.
Cherenack EM, Wilson PA, Kreuzman AM, Price GN.  2016.  The Feasibility and Acceptability of Using Technology-Based Daily Diaries with HIV-Infected Young Men Who have Sex with Men: A Comparison of Internet and Voice Modalities.. AIDS Behav. 20(8):1744-53.
Philbin MM, Tanner AE, Duval A, Ellen JM, Xu J, Kapogiannis B, Bethel J, J Fortenberry D.  2016.  HIV Testing, Care Referral, and Linkage to Care Intervals Affect Time to Engagement in Care for Newly Diagnosed HIV-Infected Adolescents in 15 Adolescent Medicine Clinics in the United States.. J Acquir Immune Defic Syndr. 72(2):222-9.
Harper GW, Serrano PA, Bruce D, Bauermeister JA.  2016.  The Internet's Multiple Roles in Facilitating the Sexual Orientation Identity Development of Gay and Bisexual Male Adolescents.. Am J Mens Health. 10(5):359-76.
Gross IMoses, Hosek S, Richards MHeather, M Fernández I.  2016.  Predictors and Profiles of Antiretroviral Therapy Adherence Among African American Adolescents and Young Adult Males Living with HIV.. AIDS Patient Care STDS. 30(7):324-38.
MacDonell KKolmodin, Jacques-Tiura AJ, Naar S, Fernandez MIsabella.  2016.  Predictors of Self-Reported Adherence to Antiretroviral Medication in a Multisite Study of Ethnic and Racial Minority HIV-Positive Youth.. J Pediatr Psychol. 41(4):419-28.
Gamarel KE, Brown L, Kahler CW, M Fernández I, Bruce D, Nichols S.  2016.  Prevalence and correlates of substance use among youth living with HIV in clinical settings.. Drug Alcohol Depend. 169:11-18.
Kahn JA, Rudy BJ, Xu J, Kapogiannis B, Secord E, Gillison M.  2016.  Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.. J Med Virol. 88(11):1944-52.
Kapogiannis BG, Leister E, Siberry GK, Van Dyke RB, Rudy B, Flynn P, Williams PL.  2016.  Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.. AIDS. 30(6):889-98.
Wilson PA, Kahana SY, Fernandez MIsabel, Harper GW, Mayer K, Wilson CM, Hightow-Weidman LB.  2016.  Sexual Risk Behavior Among Virologically Detectable Human Immunodeficiency Virus-Infected Young Men Who Have Sex With Men.. JAMA Pediatr. 170(2):125-31.
Kahana SY, Jenkins RA, Bruce D, Fernandez MI, Hightow-Weidman LB, Bauermeister JA.  2016.  Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIV.. PLoS One. 11(4):e0151106.
Tanner AE, Philbin MM, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2016.  Transitioning HIV-Positive Adolescents to Adult Care: Lessons Learned From Twelve Adolescent Medicine Clinics.. J Pediatr Nurs. 31(5):537-43.
Brothers J, Hotton AL, Hosek SG, Harper GW, M Fernández I.  2016.  Young Women Living with HIV: Outcomes from a Targeted Secondary Prevention Empowerment Pilot Trial.. AIDS Patient Care STDS. 30(5):229-35.
2015
Belzer ME, MacDonell KKolmodin, Clark LF, Huang J, Olson J, Kahana SY, Naar S, Sarr M, Thornton S.  2015.  Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Nonadherence to Antiretroviral Therapy.. AIDS Patient Care STDS. 29(6):338-45.
Alexander AB, Ott MA, Lally MA, Sniecinski K, Baker A, Zimet GD.  2015.  Adolescent decision making about participation in a hypothetical HIV vaccine trial.. Vaccine. 33(11):1331-7.
Gilbert ALewis, Knopf AS, J Fortenberry D, Hosek SG, Kapogiannis BG, Zimet GD.  2015.  Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research.. J Adolesc Health. 57(1):113-9.
Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML.  2015.  Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.. Sex Transm Dis. 42(5):246-52.
Mullins TLKowalczy, Lally M, Zimet G, Kahn JA.  2015.  Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.. AIDS Patient Care STDS. 29(4):193-203.
Havens PL, Hazra R.  2015.  Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.. Pediatr Infect Dis J. 34(4):406-8.
Saberi P, Mayer K, Vittinghoff E, Naar-King S.  2015.  Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence.. AIDS Behav. 19(1):93-103.
Ellen JM, Greenberg L, Willard N, Stines S, Korelitz J, Boyer CB.  2015.  Cross-sectional survey comparing HIV risk behaviours of adolescent and young adult men who have sex with men only and men who have sex with men and women in the U.S. and Puerto Rico.. Sex Transm Infect. 91(6):458-61.
Ellen JM, Greenberg L, Willard N, Korelitz J, Kapogiannis BG, Monte D, Boyer CB, Harper GW, Henry-Reid LM, Friedman LB et al..  2015.  Evaluation of the effect of human immunodeficiency virus-related structural interventions: the connect to protect project.. JAMA Pediatr. 169(3):256-63.
Cook SH, Valera P, Wilson PA.  2015.  HIV status disclosure, depressive symptoms, and sexual risk behavior among HIV-positive young men who have sex with men.. J Behav Med. 38(3):507-17.
Rudy BJ, Kapogiannis BG, Worrell C, Squires K, Bethel J, Li S, Wilson CM, Agwu A, Emmanuel P, Price G et al..  2015.  Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.. J Acquir Immune Defic Syndr. 69(1):52-60.
Bruce D, Kahana SY, Bauermeister JA, Nichols SL, Hightow-Weidman LB, Heinze JE, Shea J, M Fernández I.  2015.  Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS.. Drug Alcohol Depend. 151:173-80.
M Fernández I, Huszti HC, Wilson PA, Kahana S, Nichols S, Gonin R, Xu J, Kapogiannis BG.  2015.  Profiles of Risk Among HIV-Infected Youth in Clinic Settings.. AIDS Behav. 19(5):918-30.
Brown LK, Whiteley L, Harper GW, Nichols S, Nieves A.  2015.  Psychological symptoms among 2032 youth living with HIV: a multisite study.. AIDS Patient Care STDS. 29(4):212-9.
Hussen SA, Harper GW, Bauermeister JA, Hightow-Weidman LB.  2015.  Psychosocial influences on engagement in care among HIV-positive young black gay/bisexual and other men who have sex with men.. AIDS Patient Care STDS. 29(2):77-85.
Kahana SY, Fernandez MIsabel, Wilson PA, Bauermeister JA, Lee S, Wilson CM, Hightow-Weidman LB.  2015.  Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.. J Acquir Immune Defic Syndr. 68(2):169-77.
Boone MR, Cherenack EM, Wilson PA.  2015.  Self-Efficacy for Sexual Risk Reduction and Partner HIV Status as Correlates of Sexual Risk Behavior Among HIV-Positive Adolescent Girls and Women.. AIDS Patient Care STDS. 29(6):346-53.
Lee S, Yamazaki M, D Harris R, Harper GW, Ellen J.  2015.  Social Support and Human Immunodeficiency Virus-Status Disclosure to Friends and Family: Implications for Human Immunodeficiency Virus-Positive Youth.. J Adolesc Health. 57(1):73-80.
Chutuape KS, Willard N, Walker BC, Boyer CB, Ellen J.  2015.  A Tailored Approach to Launch Community Coalitions Focused on Achieving Structural Changes: Lessons Learned From a HIV Prevention Mobilization Study.. J Public Health Manag Pract. 21(6):546-55.
Willard N, Chutuape K, Stewart-Campbell R, Boyer CB, Ellen J.  2015.  Targeting Structural Change for HIV Prevention: A Process and Tool for Community Application.. Health Promot Pract. 16(6):837-48.
2014
Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Torres CMRivera, Chutuape KS, Stines SJ, Straub DM et al..  2014.  A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection.. J Adolesc Health. 55(6):765-73.
Nichols SL, Lowe A, Zhang X, Garvie PA, Thornton S, Goldberger BA, Hou W, Goodenow MM, Sleasman JW.  2014.  Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth.. Drug Alcohol Depend. 134:376-382.
Whiteley LB, Brown LK, Swenson R, Kapogiannis BG, Harper GW.  2014.  Disparities in mental health care among HIV-infected youth.. J Int Assoc Provid AIDS Care. 13(1):29-34.
Lally M, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Zimet G.  2014.  Evaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials.. J Adolesc Health. 55(2):254-9.
Brothers J, Harper GW, M Fernández I, Hosek SG.  2014.  EVOLUTION--taking charge and growing stronger: the design, acceptability, and feasibility of a secondary prevention empowerment intervention for young women living with HIV.. AIDS Patient Care STDS. 28(1):33-42.
Philbin MM, Tanner AE, Duval A, Ellen JM, Xu J, Kapogiannis B, Bethel J, J Fortenberry D.  2014.  Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen adolescent medicine clinics in the United States.. AIDS Behav. 18(8):1501-10.
Ellen JM, Kapogiannis B, J Fortenberry D, Xu J, Willard N, Duval A, Pace J, Loeb J, Monte D, Bethel J.  2014.  HIV viral load levels and CD4+ cell counts of youth in 14 cities.. AIDS. 28(8):1213-9.
Reed SJ, Miller RLin, Francisco VT.  2014.  The influence of community context on how coalitions achieve HIV-preventive structural change.. Health Educ Behav. 41(1):100-7.
Outlaw AY, Naar-King S, Tanney M, Belzer ME, Aagenes A, Parsons JT, Merlo LJ.  2014.  The initial feasibility of a computer-based motivational intervention for adherence for youth newly recommended to start antiretroviral treatment.. AIDS Care. 26(1):130-5.
Philbin MM, Tanner AE, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2014.  Linking HIV-positive adolescents to care in 15 different clinics across the United States: creating solutions to address structural barriers for linkage to care.. AIDS Care. 26(1):12-9.
Harper GW, Bruce D, Hosek SG, M Fernández I, Rood BA.  2014.  Resilience processes demonstrated by young gay and bisexual men living with HIV: implications for intervention.. AIDS Patient Care STDS. 28(12):666-76.
Harper GW, Lemos D, Hosek SG.  2014.  Stigma reduction in adolescents and young adults newly diagnosed with HIV: findings from the Project ACCEPT intervention.. AIDS Patient Care STDS. 28(10):543-54.
Esposito-Smythers C, Brown LK, Wolff J, Xu J, Thornton S, Tidey J.  2014.  Substance abuse treatment for HIV infected young people: an open pilot trial.. J Subst Abuse Treat. 46(2):244-50.
Belzer ME, Naar-King S, Olson J, Sarr M, Thornton S, Kahana SY, Gaur AH, Clark LF.  2014.  The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial.. AIDS Behav. 18(4):686-96.
Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2014.  Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.. Antivir Ther. 19(6):613-8.
Tanner AE, Philbin MM, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2014.  "Youth friendly" clinics: considerations for linking and engaging HIV-infected adolescents into care.. AIDS Care. 26(2):199-205.
2013
Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, M Fernández I, Rutledge B, Martinez J, Garofalo R et al..  2013.  The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.. J Acquir Immune Defic Syndr. 62(4):447-56.
Miller RLin, Reed SJ, Francisco V.  2013.  Accomplishing structural change: identifying intermediate indicators of success.. Am J Community Psychol. 51(1-2):232-42.
Bruce D, Kahana S, Harper GW, M Fernández I.  2013.  Alcohol use predicts sexual risk behavior with HIV-negative or partners of unknown status among young HIV-positive men who have sex with men.. AIDS Care. 25(5):559-65.
Syed SS, Balluz RS, Kabagambe EK, Meyer WA, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW.  2013.  Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.. AIDS Res Hum Retroviruses. 29(3):493-500.
Boyer CB, Hightow-Weidman L, Bethel J, Li SX, Henry-Reid L, Futterman D, Maturo D, Straub DM, Howell K, Reid S et al..  2013.  An assessment of the feasibility and acceptability of a friendship-based social network recruitment strategy to screen at-risk African American and Hispanic/Latina young women for HIV infection.. JAMA Pediatr. 167(3):289-96.
Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2013.  Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 57(11):5619-28.
MacDonell K, Naar-King S, Huszti H, Belzer M.  2013.  Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.. AIDS Behav. 17(1):86-93.
Lee S, Kapogiannis BG, Flynn PM, Rudy BJ, Bethel J, Ahmad S, Tucker D, Abdalian SEllen, Hoffman D, Wilson CM et al..  2013.  Comprehension of a simplified assent form in a vaccine trial for adolescents.. J Med Ethics. 39(6):410-2.
Reed SJ, Miller RLin.  2013.  Connect to protect and the creation of AIDS-competent communities.. AIDS Educ Prev. 25(3):255-67.
Kahn JA, Xu J, Kapogiannis BG, Rudy B, Gonin R, Liu N, Wilson CM, Worrell C, Squires KE.  2013.  Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.. Clin Infect Dis. 57(5):735-44.
Mullins TLK, Rudy BJ, Wilson CM, Sucharew H, Kahn JA.  2013.  Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA.. Int J STD AIDS. 24(2):123-7.
Naar-King S, Outlaw AY, Sarr M, Parsons JT, Belzer M, MacDonell K, Tanney M, Ondersma SJ.  2013.  Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment.. J Pediatr Psychol. 38(6):638-48.
Nichols SL, Bethel J, Garvie PA, Patton DE, Thornton S, Kapogiannis BG, Ren W, Major-Wilson H, Puga A, Woods SP.  2013.  Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.. J Adolesc Health. 53(6):763-71.
Ott MA, Alexander AB, Lally M, Steever JB, Zimet GD.  2013.  Preventive misconception and adolescents' knowledge about HIV vaccine trials.. J Med Ethics. 39(12):765-71.
Harper GW, Fernandez IM, Bruce D, Hosek SG, Jacobs RJ.  2013.  The role of multiple identities in adherence to medical appointments among gay/bisexual male adolescents living with HIV.. AIDS Behav. 17(1):213-23.
Bruce D, Harper GW, Suleta K.  2013.  Sexual risk behavior and risk reduction beliefs among HIV-positive young men who have sex with men.. AIDS Behav. 17(4):1515-23.

Pages